SCHEMBL13009197

SCHEMBL13009197

C1=Cc2ccccc2N(c2ccc3c(-c4cccc5ccccc45)c4ccc(N5c6ccccc6C=Cc6ccccc65)cc4c(-c4ccccc4)c3c2)c2ccccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.38
PDE6D O43924 1/20 0.35
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
MAPT P10636 2/20 0.32
HPGD P15428 2/20 0.32
SOS1 Q07889 1/20 0.32
TP53 P04637 1/20 0.32
TSHR P16473 1/20 0.32
NFKB1 P19838 1/20 0.32
MAPK1 P28482 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
ATM Q13315 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HSD17B10 Q99714 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ESR1 P03372 5/20 0.32
ESR2 Q92731 4/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13009413 1.00 POLB (0.38) POLBPDE6DKDM4EALDH1A1MAPT
SCHEMBL12928337 0.94 POLB (0.42) POLBPDE6DKDM4EALDH1A1MAPT
SCHEMBL13008888 0.90 POLB (0.35) POLBPDE6DSOS1P2RX4CYP1A1
SCHEMBL13009212 0.87 P2RX4 (0.34) ALDH1A1MAPTTSHRMAPK1ATM
SCHEMBL12951906 0.87 P2RX4 (0.34) ALDH1A1MAPTTSHRMAPK1ATM
SCHEMBL13008757 0.86 PDE6D (0.36) POLBPDE6DKDM4EALDH1A1MAPT
SCHEMBL13428429 0.85 PIM1 (0.36) POLBPDE6DP2RX4
SCHEMBL13427620 0.84 PDE6D (0.40) POLBPDE6DKDM4EALDH1A1MAPT
SCHEMBL13009367 0.84 PDE6D (0.34) POLBPDE6DKDM4EALDH1A1MAPT
SCHEMBL13009401 0.84 PDE6D (0.34) POLBPDE6DKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2256176-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-12-01 EP disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A POLB 913/4885PDE6D 3559/4885KDM4E 4138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.